Papers
3
Total Citations
28
H-Index
3
About
Dr. Ur Metser is a leading clinician-researcher whose work is transforming the management of head and neck cancers, particularly for patients with carcinoma of unknown primary (CUP). His research focuses on integrating transoral robotic surgery (TORS) with precisely tailored radiotherapy to reduce treatment toxicity without compromising oncologic outcomes. Dr. Metser’s major contribution is pioneering a paradigm shift away from comprehensive, high-volume pharyngeal irradiation toward targeted, de-intensified radiation fields guided by surgical and histopathological localization. As lead author of the pivotal FIND trial protocol and its phase 2 results, he demonstrated that TORS-guided volume reduction is both safe and effective for p16-positive squamous cell carcinoma, achieving excellent disease control while minimizing swallowing and salivary morbidity. His 2024 study on TORS and radiation deintensification in CUP patients further solidifies this approach, with key works accumulating over 28 citations. Dr. Metser’s work is notable for directly translating surgical innovation into practical, patient-centered radiotherapy strategies, offering a path to less toxic, more precise treatment for a challenging clinical scenario. His research is essential reading for oncologists and surgeons seeking to optimize functional outcomes in head and neck cancer care.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3